Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
Status:
Not yet recruiting
Trial end date:
2028-01-31
Target enrollment:
Participant gender:
Summary
To learn about the safety and effects of an investigational drug called nirogacestat when
given to participants with a desmoid tumor/aggressive fibromatosis